Abstract
Serine-threonine Protein phosphatase 2 A (PP2A), a member of the PPP family of phosphatases, regulates a variety of essential cellular processes, including cell-cycling, DNA replication, transcription, translation, and secondary signaling pathways. In the heart, increased PP2A activity/signaling has been linked to cardiac remodeling, contractile dysfunction and, in failure, arrythmogenicity. The core PP2A complex is a hetero-trimeric holoenzyme consisting of a 36 kDa catalytic subunit (PP2Ac); a regulatory scaffold subunit of 65 kDa (PR65A or PP2Aa); and one of at least 18 associated variable regulatory proteins (B subunits) classified into 3 families. In the present study, three in vivo sites of phosphorylation in cardiac PR65A are identified (S303, T268, S314). Using HEK cells transfected with recombinant forms of PR65A with phosphomimetic (P-PR65A) and non-phosphorylated (N-PR65A) amino acid substitutions at these sites, these phosphorylations were shown to inhibit the interaction of PR65A with PP2Ac and PP2A holoenzyme signaling. Forty-seven phospho-proteins were increased in abundance in HEK cells transfected with P-PR65A versus N-PR65A by phospho-protein profiling using 2D-DIGE analysis on phospho-enriched whole cell protein extracts. Among these proteins were elongation factor 1α (EF1A), elongation factor 2, heat shock protein 60 (HSP60), NADPH-dehydrogenase 1 alpha sub complex, annexin A, and PR65A. Compared to controls, failing hearts from the Dahl rat had less phosphorylated PR65A protein abundance and increased PP2A activity. Thus, PR65A phosphorylation is an in vivo mechanism for regulation of the PP2A signaling complex and increased PP2A activity in heart failure.
Highlights
Serine-threonine Protein phosphatase 2A (PP2A), a member of the PPP family of phosphatases, is abundant, highly conserved from yeast to humans, and regulates a variety of essential cellular processes, including cellcycling, DNA replication, transcription, and translation and multiple signaling pathways [1,2]
The PR65A phospho-peptides were identified by matrix-associated laser desorption/ ionization (MALDI)-Mass Spectrometry (MS) mass spectrometry and phosphorylated amino acids identified by MALDI-TOF
These studies show regulation of PP2A signaling in vivo by the phosphorylation of PR65A at S303, T268, and S314, via modulation of formation of the PP2A holoenzyme complex
Summary
Serine-threonine Protein phosphatase 2A (PP2A), a member of the PPP family of phosphatases, is abundant (up to 1% of total cellular protein), highly conserved from yeast to humans, and regulates a variety of essential cellular processes, including cellcycling, DNA replication, transcription, and translation and multiple signaling pathways [1,2]. It regulates a number of genes, including FOXO1, which is involved in cell cycle control and apoptosis [3] and it has been identified as a tumor suppressor [4]. The present studies were performed to determine the effect of PR65A phosphorylation on the PP2A complex and signaling
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.